Development of Metal Analogues of Prussian Blue@Silver Nanocomposites for the Treatment of Biofilm and Skin‐Infections
APMIS · 2025
DOI: 10.1111/apm.70073 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2025. Verfasst von Sangeeta Kumari und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi, UP, India. Hauptthemen laut MEDLINE: Biofilms, Ferrocyanides, Nanocomposites, Silver. Die Arbeit nennt 47 Literaturangaben. Gefördert von: CSC0302, sponsored by CSIR, New Delhi to CRP, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Silver‐based nanocomplexes are promising antibacterial agents because of their ability to break the bacterial cell membrane, enhance oxidative stress, and damage bacterial DNA, offering potential alternatives to conventional antibiotics. Recently, Prussian blue analogues nanocomposites have gained attention due to their unique advantages, including biocompatibility, low cost, and easy structural modification to induce bioactivity. Herein, we developed different metal analogues of Prussian blue@silver [M II PB@Ag, M II = Cu, Co, and Mn] nanocomposites for antibacterial applications. In vitro assays confirmed the utility of these materials in inhibiting Gram‐negative and Gram‐positive bacteria. The antibiofilm property of CuIIPB@Ag and MnIIPB@Ag was assessed by coating them on PDMS disk surfaces. The results show that CuPB@Ag (at 1600 μM) and MnPB@Ag (at 4000 μM) achieve approximately an 85% reduction in biofilm formation. In vitro cytotoxicity studies assessed by using the MTT assay support the biocompatibility of Cu II PB@Ag (up to 80% cell viability in 60 μM) and Mn II PB@Ag (up to 70% cell viability in 150 μM). Moreover, Cu II PB@Ag (at 1600 μM) and Mn II PB@Ag (at 4000 μM) eliminated in vivo skin infections in the preclinical rat model. These results highlight the potential of these metal analogues of Prussian blue@silver nanocomposites for the treatment of bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering, Indian Institute of Technology (BHU), Varanasi, UP, India.
- Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana State, India.
- Academy of Scientific & Innovative Research (AcSIR), Ghaziabad, UP, India.
ORCID-Profile: Sudip Mukherjee
Förderung
- CSC0302, sponsored by CSIR, New Delhi to CRP
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Kumari, S., Bhukya, S., Upadhyay, A., Londhe, S., Nuthi, S., Patra, C. R., & Mukherjee, S. (2025). Development of Metal Analogues of Prussian Blue@Silver Nanocomposites for the Treatment of Biofilm and Skin‐Infections. APMIS. https://doi.org/10.1111/apm.70073
Vancouver
Kumari S, Bhukya S, Upadhyay A, Londhe S, Nuthi S, Patra CR, et al. Development of Metal Analogues of Prussian Blue@Silver Nanocomposites for the Treatment of Biofilm and Skin‐Infections. APMIS. 2025. doi:10.1111/apm.70073
BibTeX
@article{Kumari2025,
author = {Kumari, Sangeeta and Bhukya, Swapna and Upadhyay, Anjali and Londhe, Swapnali and Nuthi, Saketh and Patra, Chitta Ranjan and Mukherjee, Sudip},
title = {Development of Metal Analogues of Prussian Blue@Silver Nanocomposites for the Treatment of Biofilm and Skin‐Infections},
journal = {APMIS},
year = {2025},
doi = {10.1111/apm.70073}
}
EUVIMED